NasdaqGS - Nasdaq Real Time Price USD

Neumora Therapeutics, Inc. (NMRA)

0.8262
+0.0362
+(4.58%)
As of 2:49:39 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
274,326
263,464
252,098
135,870
237,323
Operating Income
-274,326
-263,464
-252,098
-135,870
-237,323
Net Non Operating Interest Income Expense
16,642
19,933
16,611
4,561
0
Other Income Expense
-91
-78
-170
405
11
Pretax Income
-257,775
-243,609
-235,657
-130,904
-237,312
Tax Provision
283
178
268
0
--
Net Income Common Stockholders
-258,058
-243,787
-235,925
-130,904
-237,312
Diluted NI Available to Com Stockholders
-258,058
-243,787
-235,925
-130,904
-237,312
Basic EPS
-1.61
--
-3.63
-0.86
-1.56
Diluted EPS
-1.61
--
-3.63
-0.86
-1.56
Basic Average Shares
160,254
--
65,021
151,949.0960
151,949.0960
Diluted Average Shares
160,254
--
65,021
151,949.0960
151,949.0960
Total Operating Income as Reported
-274,326
-263,464
-252,098
-135,870
-237,323
Total Expenses
274,326
263,464
252,098
135,870
237,323
Net Income from Continuing & Discontinued Operation
-258,058
-243,787
-235,925
-130,904
-237,312
Normalized Income
-258,058
-243,787
-235,925
-130,904
-237,312
Interest Income
16,642
19,933
16,611
4,561
0
Net Interest Income
16,642
19,933
16,611
4,561
0
EBIT
-274,326
-263,464
-252,098
-135,870
-237,323
EBITDA
-273,696
-262,833
-251,430
-135,276
-236,785
Reconciled Depreciation
630
631
668
594
538
Net Income from Continuing Operation Net Minority Interest
-258,058
-243,787
-235,925
-130,904
-237,312
Normalized EBITDA
-273,696
-262,833
-251,430
-135,276
-236,785
Tax Rate for Calcs
0.0002
0.0002
0.0002
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 9/14/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ALLO Allogene Therapeutics, Inc.
1.3050
+1.16%
 
DAWN Day One Biopharmaceuticals, Inc.
6.94
+0.14%
 
ACRV Acrivon Therapeutics, Inc.
1.2699
+3.24%
 
CRGX CARGO Therapeutics, Inc.
4.5700
+0.44%
 
QTTB Q32 Bio Inc.
1.8600
-3.63%
 
CTNM Contineum Therapeutics, Inc.
4.1600
-5.67%
 
GBIO Generation Bio Co.
0.3701
-4.47%
 
FATE Fate Therapeutics, Inc.
1.3750
-3.17%
 
CCCC C4 Therapeutics, Inc.
1.4700
-4.55%
 
IGMS IGM Biosciences, Inc.
1.2650
+0.40%